The decay of both NGF and BDNF in AD brains has been attributed to receptor downregulation (tropomyosin receptor kinase A (TrkA) for NGF and tropomyosin receptor kinase B (TrkB) for BDNF). This evidence concerns the gene NTRK1 and Alzheimer disease.